Table 1.
Baseline Characteristics.
| Characteristic | Rocuronium patients (N = 71) |
|---|---|
| Reasons for respiratory failurea | |
| COVID-19 | 59 (83.1) |
| Non-COVID-19 related | 12 (16.9) |
| Medical | 9 (12.7) |
| Trauma | 1 (1.4) |
| Airway protection | 1 (1.4) |
| Malignancy | 1 (1.4) |
| Age, yearsb | 56 (47-63) |
| Malea | 51 (71.8) |
| Dosing weight, kgb | 85 (72.9-103) |
| Past medical historya | |
| Chronic kidney disease | 11 (15.5) |
| Acute kidney injury | 38 (53.5) |
| Liver dysfunction | 2 (2.8) |
| APACHE IIb | 21 (17-26) |
| Extracorporeal membrane oxygenation a | 10 (14.1) |
| Ventilator metrics at initiation of paralytics: b | |
| FiO2, % | 70 (51.2-90) |
| PaO2, mmHg | 82 (70-104) |
| PaO2/FiO2 | 127.6 (104.2-168.5) |
| Tidal volume/ideal body weight, mL/kg | 6 (5.6-6.4) |
Abbreviations: APACHE II, The Acute Physiology and Chronic Health Evaluation II; COVID-19, Coronavirus-19; FiO2, Fraction of inspired oxygen; PaO2, Partial pressure of oxygen.
an (%),
bMedian (IQR).